Previously, we showed that the PERK-eIF2α pathway, which is part of the integrated stress response (ISR), is activated in CD34+ CML-BP cells and is correlated with disease progression and resistance to TKIs [14]. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.